Free Trial

Aethlon Medical (AEMD) Competitors

Aethlon Medical logo
$0.58 +0.15 (+33.83%)
(As of 12/20/2024 05:45 PM ET)

AEMD vs. MBOT, NRXS, NEPH, LUCY, IINN, LFWD, MHUA, SSKN, LYRA, and PYPD

Should you be buying Aethlon Medical stock or one of its competitors? The main competitors of Aethlon Medical include Microbot Medical (MBOT), NeurAxis (NRXS), Nephros (NEPH), Innovative Eyewear (LUCY), Inspira Technologies Oxy B.H.N. (IINN), ReWalk Robotics (LFWD), Meihua International Medical Technologies (MHUA), STRATA Skin Sciences (SSKN), Lyra Therapeutics (LYRA), and PolyPid (PYPD). These companies are all part of the "medical equipment" industry.

Aethlon Medical vs.

Aethlon Medical (NASDAQ:AEMD) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, community ranking, profitability and institutional ownership.

Aethlon Medical's return on equity of -160.36% beat Microbot Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Aethlon MedicalN/A -160.36% -115.74%
Microbot Medical N/A -218.30%-158.17%

Aethlon Medical has a beta of 1.79, indicating that its stock price is 79% more volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.62, indicating that its stock price is 62% more volatile than the S&P 500.

In the previous week, Aethlon Medical had 2 more articles in the media than Microbot Medical. MarketBeat recorded 2 mentions for Aethlon Medical and 0 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 1.30 beat Aethlon Medical's score of 0.32 indicating that Microbot Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Aethlon Medical Neutral
Microbot Medical Positive

Microbot Medical has lower revenue, but higher earnings than Aethlon Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aethlon Medical$570K14.21-$12.21M-$2.82-0.21
Microbot MedicalN/AN/A-$10.74M-$0.80-1.21

Microbot Medical received 129 more outperform votes than Aethlon Medical when rated by MarketBeat users. Likewise, 70.67% of users gave Microbot Medical an outperform vote while only 51.78% of users gave Aethlon Medical an outperform vote.

CompanyUnderperformOutperform
Aethlon MedicalOutperform Votes
218
51.78%
Underperform Votes
203
48.22%
Microbot MedicalOutperform Votes
347
70.67%
Underperform Votes
144
29.33%

2.0% of Aethlon Medical shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 1.1% of Aethlon Medical shares are owned by insiders. Comparatively, 10.5% of Microbot Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Aethlon Medical presently has a consensus price target of $7.00, indicating a potential upside of 1,106.90%. Microbot Medical has a consensus price target of $7.00, indicating a potential upside of 621.65%. Given Aethlon Medical's higher probable upside, equities research analysts clearly believe Aethlon Medical is more favorable than Microbot Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aethlon Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Microbot Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Aethlon Medical and Microbot Medical tied by winning 7 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AEMD vs. The Competition

MetricAethlon MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$8.10M$4.34B$5.13B$9.07B
Dividend YieldN/A44.57%5.08%4.23%
P/E Ratio-0.2125.3789.5817.17
Price / Sales14.2145.951,116.12116.95
Price / CashN/A43.4542.8237.86
Price / Book0.267.094.774.78
Net Income-$12.21M$13.64M$120.15M$225.60M
7 Day Performance61.74%-2.93%-1.92%-1.23%
1 Month Performance48.99%0.28%11.47%3.36%
1 Year Performance-69.31%40.76%30.54%16.60%

Aethlon Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AEMD
Aethlon Medical
3.0781 of 5 stars
$0.58
+33.8%
$7.00
+1,106.9%
-68.6%$8.10M$570,000.00-0.2110Analyst Forecast
News Coverage
Gap Up
High Trading Volume
MBOT
Microbot Medical
2.6578 of 5 stars
$1.01
+0.9%
$7.00
+593.5%
-28.7%$17.09MN/A-1.2520
NRXS
NeurAxis
N/A$2.43
-2.0%
N/A+13.7%$16.96M$2.46M-1.3519Gap Down
NEPH
Nephros
1.6925 of 5 stars
$1.54
-0.6%
$5.00
+224.7%
-50.0%$16.24M$13.55M-17.2230Positive News
LUCY
Innovative Eyewear
1.7088 of 5 stars
$6.39
+4.6%
$20.00
+213.0%
-34.1%$15.60M$1.56M-0.639Positive News
IINN
Inspira Technologies Oxy B.H.N.
0.3085 of 5 stars
$1.12
-4.3%
N/A-21.2%$14.14MN/A0.0020Gap Down
LFWD
ReWalk Robotics
3.3589 of 5 stars
$1.54
-6.7%
$13.00
+744.2%
N/A$13.56M$25.00M-0.6260Positive News
Gap Up
High Trading Volume
MHUA
Meihua International Medical Technologies
0.6851 of 5 stars
$0.51
+2.3%
N/A-87.5%$12.85M$94.25M0.00620Gap Down
SSKN
STRATA Skin Sciences
1.0262 of 5 stars
$2.99
-0.3%
N/A-54.7%$12.47M$32.68M-1.11120
LYRA
Lyra Therapeutics
2.4114 of 5 stars
$0.19
+2.2%
$4.50
+2,311.6%
-96.0%$12.21M$1.47M-0.1250Gap Down
PYPD
PolyPid
2.3344 of 5 stars
$2.44
-6.5%
$12.00
+391.8%
-15.5%$11.71MN/A-0.3080Analyst Revision
High Trading Volume

Related Companies and Tools


This page (NASDAQ:AEMD) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners